Publications

Safety Communications

  Search All Categories
 |  

Dear Healthcare Professional Letters [ 16 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
1Increased risk of thrombo-embolic events in patients with anti-phopholipid syndrome (APS) treated with Pradaxa V11.123-Aug-20191 MB
1Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers - 1 August 2019V11.116-Aug-2019181 KB
1-Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers 31 July 2019V11.116-Aug-2019334 KB
1 Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers -26 June 2019V11.116-Aug-2019434 KB
1Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers - 19 June 2019V11.116-Aug-2019406 KB

Forms [ 1 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
1Adverse Reaction and Quality Problem ReportingV55.128-May-2019660 KB

Medicines Safety Alerts [ 6 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
21.5 MSA gamma benzine hexachlorideV104-Jun-2012154 KB
21.6MSA cough and cold medicinesV104-Jun-20121 MB
21.4MSA atypical antipsychoticsV215-Jun-2009155 KB
21.3MSA RotarixV103-Mar-2008131 KB
21.2MSA promethazineV103-Sep-200735 KB